USCB Financial (USCB) EVP reports insider share move and 15,000 options

Rhea-AI Filing Summary

USCB Financial Holdings, Inc. executive Maricarmen Logrono reported a small insider share transaction and updated equity holdings. As EVP and Chief Risk Officer, Logrono recorded a disposition coded “F” of 581 shares of Class A Voting Common Stock on January 21, 2026 at $20.38 per share, leaving 10,132 shares beneficially owned directly.

The filing also shows options to purchase 15,000 shares of Class A Voting Common Stock at an exercise price of $12.05 per share, expiring on September 27, 2031. Footnotes explain that the 10,132 common shares include multiple restricted stock grants that each vest in one-third annual installments, and that the options vest in one-third annual installments beginning on the first anniversary of the September 27, 2021 grant date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Logrono Maricarmen

(Last) (First) (Middle)

C/O USCB FINANCIAL HOLDINGS, INC.

2301 N.W. 87TH AVENUE

(Street)

DORAL FL 33172

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
USCB FINANCIAL HOLDINGS, INC. [ USCB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Chief Risk Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Voting Common Stock	01/21/2026		F		581	D	$20.38	10,132(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to Purchase Class A Voting Stock	$12.05							09/27/2022(2)	09/27/2031	Class A Voting Common Stock	15,000		15,000	D

Explanation of Responses:

1. Includes 876 shares of restricted stock from a grant of 2,630 shares which commenced vesting at a rate of one-third per year on January 22, 2025, 808 shares of restricted stock from a grant of 2,426 shares which commenced vesting at a rate of one-third per year on March 8, 2024, and 3,920 shares of restricted stock from a grant of 5,880 shares which commenced vesting at a rate of one-third per year on January 21, 2026.

2. The options vest at a rate of one-third per year commencing on the first anniversary of the date of grant, which was 9/27/2021.

	/s/ Robert Anderson by P.O.A. for Maricarmen Logrono	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did USCB EVP Maricarmen Logrono report on this Form 4 for USCB?

Maricarmen Logrono, EVP and Chief Risk Officer of USCB Financial Holdings, Inc., reported a disposition coded “F” of 581 shares of Class A Voting Common Stock on January 21, 2026 at $20.38 per share, leaving 10,132 shares beneficially owned directly.

How many USCB common shares does Maricarmen Logrono beneficially own after the reported Form 4 transaction?

After the reported transaction, Maricarmen Logrono beneficially owns 10,132 shares of USCB Class A Voting Common Stock directly, including several restricted stock grants that vest over time.

What stock options are reported for Maricarmen Logrono in this USCB Form 4 filing?

The filing lists options to purchase 15,000 shares of USCB Class A Voting Common Stock at an exercise price of $12.05 per share, expiring on September 27, 2031. These options vest in one-third annual installments starting on the first anniversary of the September 27, 2021 grant date.

How are Maricarmen Logrono’s restricted stock awards in USCB structured?

The explanation notes that the reported holdings include restricted stock from three grants: 2,630 shares vesting one-third per year from January 22, 2025, 2,426 shares vesting one-third per year from March 8, 2024, and 5,880 shares vesting one-third per year from January 21, 2026. Portions of these grants remain unvested within the 10,132-share total.

Is Maricarmen Logrono’s ownership in USCB reported as direct or indirect on this Form 4?

The Form 4 shows both the 10,132 common shares and the 15,000 stock options as held with direct (D) ownership by Maricarmen Logrono, with no indirect ownership entity described.

What is Maricarmen Logrono’s role at USCB Financial Holdings, Inc. as noted in the Form 4?

The filing identifies Maricarmen Logrono as an officer of USCB Financial Holdings, Inc., serving as EVP and Chief Risk Officer.